Christian Brühlmann
Corporate Officer/Principal chez ONCONETIX, INC.
Fortune : 48 622 $ au 31/05/2024
Postes actifs de Christian Brühlmann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ONCONETIX, INC. | Corporate Officer/Principal | 01/12/2023 | - |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Fondateur | 01/01/2010 | - |
| Corporate Officer/Principal | 01/11/2018 | - | |
| Directeur/Membre du Conseil | 01/01/2010 | 01/11/2018 | |
| Directeur des opérations | 01/01/2010 | 01/11/2018 | |
| Directeur Financier/CFO | 01/01/2010 | 01/11/2018 |
Historique de carrière de Christian Brühlmann
Formation de Christian Brühlmann
| University of Zurich | Masters Business Admin |
Statistiques
Internationale
| Suisse | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Bourse
- Insiders
- Christian Brühlmann
- Expérience
